V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006713 | 220002580 | 1.66 | 65.8 | null | 2017-12-19 | 2017-12-19 | FLAG + Idarubicin | N | N | 220030858 | FLAG + IDARUBICIN |
| 220006714 | 220002580 | 0 | 136.3 | Curative (C) | null | 2018-05-16 | Nilotinib | 2 | N | 220030858 | NILOTINIB |
| 220006715 | 220002581 | null | null | Curative (C) | 2017-10-05 | 2017-10-15 | AML MyeChild 01 A Mitozantrone/Cytarabine | 2 | N | 220030880 | NOT MATCHED |
| 220006716 | 220002581 | 1.78 | 85 | Curative (C) | 2014-06-03 | 2014-06-08 | FLAG + Idarubicin | N | N | 220030880 | FLAG + IDARUBICIN |
| 220006717 | 220002581 | 0 | null | Disease modification (D) | null | 2013-01-17 | Nilotinib | 02 | N | 220030880 | NILOTINIB |
| 220006718 | 220018854 | 1.63 | 80 | Curative (C) | 2016-12-08 | 2016-12-08 | AML 19 TRIAL | Y | null | 220030885 | AML19 TRIAL |
| 220006719 | 220018854 | 1.78 | null | Curative (C) | 2015-07-30 | 2015-08-10 | FLAG + Idarubicin | N | N | 220030885 | FLAG + IDARUBICIN |
| 220006720 | 220002582 | 1.56 | 52.7 | Curative (C) | 2014-09-13 | 2014-09-13 | AML MyeChild 01 Triple IT | N | N | 220030887 | NOT MATCHED |
| 220006721 | 220011493 | 1.69 | 52.2 | Curative (C) | 2013-07-14 | 2013-07-14 | AML 19 TRIAL | 1 | N | 220030888 | AML19 TRIAL |
| 220006722 | 220002583 | null | 85 | Curative (C) | 2016-05-03 | 2016-05-04 | AML 19 TRIAL + CYTARABINE + FLUDARABINE + IDARUBICIN + mylotarg | Y | N | 220030890 | NOT MATCHED |
| 220006723 | 220002583 | 1.62 | 85 | Curative (C) | 2016-08-01 | 2016-08-01 | AML 19 TRIAL | 01 | N | 220030890 | AML19 TRIAL |
| 220006724 | 220002583 | 1.56 | 91.3 | Curative (C) | 2013-08-13 | 2013-08-13 | AML 19 TRIAL | 01 | N | 220030890 | AML19 TRIAL |
| 220006725 | 220002583 | 1.71 | 89 | Curative (C) | 2014-08-20 | 2014-08-20 | AML 19 TRIAL | Y | N | 220030890 | AML19 TRIAL |
| 220006726 | 220002584 | 1.53 | 75 | Curative (C) | 2015-12-12 | 2015-12-12 | FLAG + Idarubicin | 02 | N | 220030901 | FLAG + IDARUBICIN |
| 220006730 | 220002585 | 1.94 | 74.6 | Curative (C) | 2014-09-28 | 2014-09-29 | AML Interim Guidelines FLAG-Ida | 02 | N | 220030915 | FLAG + IDARUBICIN |
| 220006732 | 220011496 | 1.56 | 78 | Curative (C) | 2013-09-27 | 2013-10-05 | AML 19 TRIAL | 01 | N | 220030919 | AML19 TRIAL |
| 220006733 | 220002587 | 1.67 | 63 | Adjuvant (A) | 2014-08-28 | 2014-08-29 | FLAG + Idarubicin | N | N | 220030921 | FLAG + IDARUBICIN |
| 220006734 | 220002587 | 1.7 | 62.1 | Curative (C) | 2016-10-05 | 2016-10-05 | AML 19 TRIAL | 1 | N | 220030921 | AML19 TRIAL |
| 220006735 | 220002587 | null | null | Curative (C) | null | 2017-09-18 | Nilotinib | N | N | 220030921 | NILOTINIB |
| 220006736 | 220002588 | null | 20.8 | Curative (C) | 2013-11-02 | 2013-11-02 | null | N | N | 220030929 | NOT MATCHED |
| 220006737 | 220011498 | null | 46.2 | Curative (C) | 2015-12-14 | 2015-12-23 | AML MyeChild 01 IT Cyt | N | N | 220030930 | NOT MATCHED |
| 220006738 | 220002589 | null | 111 | Disease modification (D) | 2014-04-11 | 2014-04-11 | Nilotinib | N | N | 220030931 | NILOTINIB |
| 220006739 | 220002589 | 1.76 | 73 | Curative (C) | 2017-05-19 | 2017-05-30 | FLAG + Idarubicin | Y | N | 220030931 | FLAG + IDARUBICIN |
| 220006740 | 220002590 | 1.9 | 80.7 | Curative (C) | 2017-06-14 | 2017-06-15 | AML 19 TRIAL | 1 | null | 220030939 | AML19 TRIAL |
| 220006741 | 220002591 | 0 | 64 | Curative (C) | 2016-04-26 | 2016-04-26 | Nilotinib | N | N | 220030940 | NILOTINIB |
| 220006742 | 220002591 | 1.59 | 53.9 | Curative (C) | 2016-03-05 | 2016-03-05 | AML 19 TRIAL | Y | N | 220030940 | AML19 TRIAL |
| 220006743 | 220002592 | 1.56 | null | null | 2014-02-14 | 2014-02-17 | AML Interim Guidelines FLAG-Ida | 99 | null | 220030945 | FLAG + IDARUBICIN |
| 220006744 | 220002592 | 1.75 | 78.9 | Curative (C) | 2014-01-07 | 2014-01-07 | AML 19 TRIAL | 02 | N | 220030945 | AML19 TRIAL |
| 220006745 | 220016185 | 0 | null | Adjuvant (A) | 2015-11-05 | 2015-11-16 | Nilotinib | N | N | 220030952 | NILOTINIB |
| 220006746 | 220016185 | null | null | Disease modification (D) | null | 2014-02-13 | Nilotinib | N | N | 220030952 | NILOTINIB |
| 220006747 | 220016185 | null | 105.5 | Curative (C) | 2017-04-15 | 2017-04-18 | AML 19 TRIAL | 01 | N | 220030952 | AML19 TRIAL |
| 220006748 | 220016185 | 0 | 0 | Disease modification (D) | 2014-06-03 | 2014-06-03 | Nilotinib | N | N | 220030952 | NILOTINIB |
| 220006749 | 220002593 | 1.8 | 68.2 | Curative (C) | null | 2016-10-20 | AML 19 TRIAL | N | N | 220030959 | AML19 TRIAL |
| 220006750 | 220002593 | 1.68 | 80.2 | Curative (C) | 2014-05-06 | 2014-05-12 | AML 19 TRIAL | 01 | N | 220030959 | AML19 TRIAL |
| 220006751 | 220002594 | 0 | 67.8 | null | 2016-05-05 | 2016-05-16 | Nilotinib | 02 | N | 220030961 | NILOTINIB |
| 220006752 | 220002595 | 1.53 | 81.9 | Curative (C) | null | 2013-08-25 | FLAG + Idarubicin | 1 | N | 220030962 | FLAG + IDARUBICIN |
| 220006753 | 220002595 | null | 95 | Curative (C) | 2017-11-11 | 2017-11-12 | AML 19 TRIAL | Y | N | 220030962 | AML19 TRIAL |
| 220006754 | 220002596 | null | 66.2 | Disease modification (D) | 2014-04-15 | 2014-04-15 | Nilotinib | N | N | 220030966 | NILOTINIB |
| 220006755 | 220011504 | null | 76 | Curative (C) | 2013-09-26 | 2014-08-15 | AML MyeChild 01 IT Cyt | Y | N | 220030967 | NOT MATCHED |
| 220006756 | 220011504 | 1.7 | 82.8 | Curative (C) | 2013-08-24 | 2013-08-25 | AML 19 TRIAL | Y | N | 220030967 | AML19 TRIAL |
| 220006757 | 220002597 | 1.65 | 73 | null | 2016-08-08 | 2016-08-08 | FLAG + Idarubicin | N | N | 220030970 | FLAG + IDARUBICIN |
| 220006758 | 220002597 | null | 0 | Curative (C) | 2013-11-17 | 2013-11-18 | Nilotinib | N | null | 220030970 | NILOTINIB |
| 220006759 | 220002598 | null | null | Curative (C) | 2017-07-14 | 2017-07-14 | FLAG + Idarubicin | 02 | N | 220030973 | FLAG + IDARUBICIN |
| 220006760 | 220002598 | 1.62 | 76.7 | Curative (C) | 2016-01-27 | 2016-01-27 | AML 19 TRIAL | N | N | 220030973 | AML19 TRIAL |
| 220006761 | 220002599 | null | null | Curative (C) | 2015-04-18 | 2015-04-18 | Nilotinib | 02 | N | 220030977 | NILOTINIB |
| 220006762 | 220002599 | 1.63 | 103.4 | Neo-adjuvant (N) | 2017-10-06 | 2017-10-06 | FLAG + Idarubicin | N | N | 220030977 | FLAG + IDARUBICIN |
| 220006763 | 220002599 | null | 0 | Curative (C) | null | 2014-03-28 | Nilotinib | 2 | N | 220030977 | NILOTINIB |
| 220006764 | 220002600 | 1.75 | null | Curative (C) | 2013-04-25 | 2013-04-25 | Nilotinib | Y | N | 220030987 | NILOTINIB |
| 220006765 | 220002600 | null | null | Curative (C) | 2015-06-30 | 2015-07-02 | AML Interim Guidelines FLA -Ida | 2 | N | 220030987 | NOT MATCHED |
| 220006766 | 220002600 | null | 81 | Curative (C) | 2018-09-27 | 2018-09-27 | Nilotinib | N | N | 220030987 | NILOTINIB |